Key facts
- This page summarizes Harsha Murthy's Form 4 filing for BioCorRx Inc. (BICX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Apr 2024, 09:51.
Harsha Murthy - 02 Jan 2024 Form 4 Insider Report for BioCorRx Inc. (BICX)
- Reporting relationship
- Director
- Issuer ticker
- BICX
- Reported as of
- 02 Jan 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Apr 2024, 09:51:11 UTC
- Prior SEC filing
- 02 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Harsha Murthy
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Harsha Murthy filed Form 4 for BioCorRx Inc. (BICX) on 03 Apr 2024.
Change
- Previous filing in this sequence was filed on 02 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +6,173
- Change %
- +77%
- Price
- $0.000000
- Shares after
- 14,153
- Date
- 02 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +5,566
- Change %
- +39%
- Price
- $0.000000
- Shares after
- 19,719
- Date
- 28 Mar 2024
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares were issued to Mr. Murthy pursuant to a Director Agreement, dated January 20, 2023, by and between BioCorRx Inc. and Mr. Murthy. As compensation for his services, Mr. Murthy shall be issued, upon the last day of each fiscal quarter, provided Mr. Murthy is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.81.
Footnote F2
These shares were issued to Mr. Murthy pursuant to a Director Agreement, dated January 20, 2023, by and between BioCorRx Inc. and Mr. Murthy. As compensation for his services, Mr. Murthy shall be issued, upon the last day of each fiscal quarter, provided Mr. Murthy is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90.